首页> 外文期刊>Journal of the American Veterinary Medical Association >Evaluation of diphenhydramine as a sedative for dogs
【24h】

Evaluation of diphenhydramine as a sedative for dogs

机译:评价苯海拉明作为狗的镇静剂

获取原文
获取原文并翻译 | 示例
           

摘要

Diphenhydramine is an HI receptor antagonist used in a variety of allergic conditions. Because of its antihis-taminic and anticholinergic properties, it may cause sedation as an adverse effect in humans. Because of this effect, many practitioners usediphenhydramine for mild sedation in dogs, including sedation for travel, during stressful experiences, or before anesthetic induction. Diphenhydramine is frequently used in our hospital as a pre-medication agent before anesthesia in patients with mast cell tumors in an attempt to decrease histamine effects that result from degranulation of mast cells associated with tumor manipulation. Diphenhydramine is inexpensive, is not a controlled substance, causes minimal cardiovascular suppression, and is readily accessible to general practitioners. All these qualities make it a potentially valuable drug for use as a sedative before anesthesia.
机译:苯海拉明是用于多种过敏性疾病的HI受体拮抗剂。由于其抗组胺和抗胆碱能特性,它可能引起镇静作用,对人体产生不利影响。由于这种作用,许多从业人员使用苯海拉明在犬中进行轻度镇静,包括在旅途中,在有压力的经历中或在麻醉诱导之前进行镇静。苯海拉明在我们的医院中经常被用作肥大​​细胞瘤患者麻醉前的预用药,以试图减少肥大细胞脱颗粒与肿瘤处理相关的组胺效应。苯海拉明价格便宜,不是受控物质,对心血管的抑制作用很小,并且全科医生很容易获得。所有这些特性使它成为麻醉前用作镇静剂的潜在有价值的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号